tiprankstipranks
Trending News
More News >
M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal
PremiumMarket NewsM&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal
2d ago
Morning Movers: CureVac skyrockets after $1.25B deal to be acquired by BioNTech
Premium
The Fly
Morning Movers: CureVac skyrockets after $1.25B deal to be acquired by BioNTech
2d ago
M&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer Pipeline
Premium
Market News
M&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer Pipeline
2d ago
CureVac price target lowered to $2 from $2.50 at BofA
PremiumThe FlyCureVac price target lowered to $2 from $2.50 at BofA
24d ago
CureVac N.V. Reports Q1 2025 Financial Results Amid Strategic Restructuring
Premium
Company Announcements
CureVac N.V. Reports Q1 2025 Financial Results Amid Strategic Restructuring
24d ago
CureVac Reports Q1 2025 Financial Results Amid Revenue Decline
Premium
Company Announcements
CureVac Reports Q1 2025 Financial Results Amid Revenue Decline
25d ago
CureVac Secures Key Patent Victory in Litigation with BioNTech
PremiumCompany AnnouncementsCureVac Secures Key Patent Victory in Litigation with BioNTech
30d ago
CureVac price target lowered to $12 from $13 at UBS
Premium
The Fly
CureVac price target lowered to $12 from $13 at UBS
2M ago
CureVac’s Uncertain Prospects Amid Operational Restructuring and Pipeline Challenges
Premium
Ratings
CureVac’s Uncertain Prospects Amid Operational Restructuring and Pipeline Challenges
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100